Maria Barrera,
Clayful
Scale the Bright Spots
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
Richard Scheller lays out the complex steps involved in the early research and subsequent development of drug products. As Genentech’s Executive Vice President of Research and Early Development, Scheller directs the early stages of the process before handing off produced molecules for further development by the company. Scheller admits that while research is his clear focus, he respects the incredible logistical challenges of trying to bring a product to market.
